McGuire V - Search Results

1

Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer risk.

Pearce CL, Doherty JA, Van Den Berg DJ, Moysich K, Hsu C, Cushing-Haugen KL, Conti DV, Ramus SJ, Gentry-Maharaj A, Menon U, Gayther SA, Pharoah PD, Song H, Kjaer SK, Hogdall E, Hogdall C, Whittemore AS, McGuire V, Sieh W, Gronwald J, Medrek K, Jakubowska A, Lubinski J, Chenevix-Trench G; AOCS/ACS Study Group; Beesley J, Webb PM, Berchuck A, Schildkraut JM, Iversen ES, Moorman PG, Edlund CK, Stram DO, Pike MC, Ness RB, Rossing MA, Wu AH. Pearce CL, et al. Among authors: mcguire v. Hum Mol Genet. 2011 Jun 1;20(11):2263-72. doi: 10.1093/hmg/ddr087. Epub 2011 Mar 21. Hum Mol Genet. 2011. PMID: 21422097 Free PMC article.

2

Survival among U.S. women with invasive epithelial ovarian cancer.

McGuire V, Jesser CA, Whittemore AS. McGuire V, et al. Gynecol Oncol. 2002 Mar;84(3):399-403. doi: 10.1006/gyno.2001.6536. Gynecol Oncol. 2002. PMID: 11855877

3

Race, epithelial ovarian cancer survival, and membership in a large health maintenance organization.

McGuire V, Herrinton L, Whittemore AS. McGuire V, et al. Epidemiology. 2002 Mar;13(2):231-4. doi: 10.1097/00001648-200203000-00021. Epidemiology. 2002. PMID: 11880767

4

Analysis of the human progesterone receptor gene polymorphism PROGINS in Austrian ovarian cancer patients.

Whittemore AS, McGuire V. Whittemore AS, et al. Among authors: mcguire v. Int J Cancer. 2002 Sep 10;101(2):202; author reply 203. doi: 10.1002/ijc.10571. Int J Cancer. 2002. PMID: 12210000 No abstract available.

5

Observational studies and randomized trials of hormone replacement therapy: what can we learn from them?

Whittemore AS, McGuire V. Whittemore AS, et al. Among authors: mcguire v. Epidemiology. 2003 Jan;14(1):8-10. doi: 10.1097/00001648-200301000-00005. Epidemiology. 2003. PMID: 12500037 No abstract available.

6

The effects of BRCA1 missense variants V1804D and M1628T on transcriptional activity.

Ostrow KL, McGuire V, Whittemore AS, DiCioccio RA. Ostrow KL, et al. Among authors: mcguire v. Cancer Genet Cytogenet. 2004 Sep;153(2):177-80. doi: 10.1016/j.cancergencyto.2004.01.020. Cancer Genet Cytogenet. 2004. PMID: 15350310

7

STK15 polymorphisms and association with risk of invasive ovarian cancer.

Dicioccio RA, Song H, Waterfall C, Kimura MT, Nagase H, McGuire V, Hogdall E, Shah MN, Luben RN, Easton DF, Jacobs IJ, Ponder BA, Whittemore AS, Gayther SA, Pharoah PD, Kruger-Kjaer S. Dicioccio RA, et al. Among authors: mcguire v. Cancer Epidemiol Biomarkers Prev. 2004 Oct;13(10):1589-94. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15466974

8

Prevalence of BRCA1 mutation carriers among U.S. non-Hispanic Whites.

Whittemore AS, Gong G, John EM, McGuire V, Li FP, Ostrow KL, Dicioccio R, Felberg A, West DW. Whittemore AS, et al. Among authors: mcguire v. Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2078-83. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15598764

9

Histologic types of epithelial ovarian cancer: have they different risk factors?

Kurian AW, Balise RR, McGuire V, Whittemore AS. Kurian AW, et al. Among authors: mcguire v. Gynecol Oncol. 2005 Feb;96(2):520-30. doi: 10.1016/j.ygyno.2004.10.037. Gynecol Oncol. 2005. PMID: 15661246

10

Breast and ovarian cancer in relatives of cancer patients, with and without BRCA mutations.

Lee JS, John EM, McGuire V, Felberg A, Ostrow KL, DiCioccio RA, Li FP, Miron A, West DW, Whittemore AS. Lee JS, et al. Among authors: mcguire v. Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):359-63. doi: 10.1158/1055-9965.EPI-05-0687. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16492929

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

205 results

Search Page

Filters